platelet: be low in kidney disease

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents blood cell
Weight: 0.64
, particle
Weight: 0.63
, white blood cell
Weight: 0.55
, blood transfusion
Weight: 0.55
, tissue
Weight: 0.54
Siblings red blood cell
Weight: 0.37
, leukocyte
Weight: 0.35
, neutrophil
Weight: 0.35

Related properties

Property Similarity
be low in kidney disease 1.00
be low with liver disease 0.95
be decreased in liver disease 0.88
be low in cancer patients 0.85
be low in leukemia 0.85
be high in cancer patients 0.84
be given to leukemia patients 0.83
be high in infection 0.82
be high in pneumonia 0.81
be given to cancer patients 0.80

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.51
Rule weight: 0.66
Evidence weight: 0.95
Similarity weight: 0.80
Evidence: 0.94
Plausible(blood transfusion, be given to cancer patients) ⋁
Evidence: 0.82
¬ Typical(platelet, be low in kidney disease)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.80
Similarity weight: 0.80
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.94
¬ Plausible(blood transfusion, be given to cancer patients)

Remarkability exclusitivity betweem a parent and a child

0.30
Rule weight: 0.58
Evidence weight: 0.65
Similarity weight: 0.80
Evidence: 0.67
¬ Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.53
¬ Remarkable(blood transfusion, be given to cancer patients)

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.85
Evidence: 0.67
¬ Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.40
¬ Remarkable(neutrophil, be low in leukemia)

Remarkability from parent implausibility

0.33
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.80
Evidence: 0.94
Plausible(blood transfusion, be given to cancer patients) ⋁
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.78
¬ Plausible(platelet, be low in kidney disease)

Remarkability from sibling implausibility

0.46
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.85
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.40
Remarkable(neutrophil, be low in leukemia) ⋁
Evidence: 0.73
¬ Plausible(neutrophil, be low in leukemia)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.86
¬ Salient(platelet, be low in kidney disease)

Similarity expansion

0.72
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.95
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.75
¬ Salient(platelet, be low with liver disease)
0.70
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.95
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.71
¬ Typical(platelet, be low with liver disease)
0.69
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.95
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.67
¬ Plausible(platelet, be low with liver disease)
0.67
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.88
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.78
¬ Salient(platelet, be decreased in liver disease)
0.66
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.88
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.61
¬ Typical(platelet, be decreased in liver disease)
0.65
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.85
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.72
¬ Salient(platelet, be low in leukemia)
0.64
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.88
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.64
¬ Plausible(platelet, be decreased in liver disease)
0.64
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.82
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.51
¬ Typical(platelet, be high in infection)
0.64
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.95
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.65
¬ Remarkable(platelet, be low with liver disease)
0.63
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.83
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.75
¬ Salient(platelet, be given to leukemia patients)
0.63
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.81
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.65
¬ Salient(platelet, be high in pneumonia)
0.63
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.82
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.78
¬ Salient(platelet, be high in infection)
0.62
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.85
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.43
¬ Remarkable(platelet, be low in leukemia)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.82
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.59
¬ Plausible(platelet, be high in infection)
0.61
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.85
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.85
¬ Typical(platelet, be low in leukemia)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.80
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.82
¬ Salient(platelet, be given to cancer patients)
0.61
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.85
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.74
¬ Plausible(platelet, be low in leukemia)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.83
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.43
¬ Remarkable(platelet, be given to leukemia patients)
0.60
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.81
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.40
¬ Remarkable(platelet, be high in pneumonia)
0.59
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.87
¬ Typical(platelet, be given to leukemia patients)
0.59
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.76
¬ Plausible(platelet, be given to leukemia patients)
0.59
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.68
¬ Plausible(platelet, be high in pneumonia)
0.59
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.81
¬ Typical(platelet, be high in pneumonia)
0.59
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.80
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.45
¬ Remarkable(platelet, be given to cancer patients)
0.57
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.80
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.92
¬ Typical(platelet, be given to cancer patients)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.80
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.82
¬ Plausible(platelet, be given to cancer patients)
0.56
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.88
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.77
¬ Remarkable(platelet, be decreased in liver disease)
0.51
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.82
Evidence: 0.67
Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.84
¬ Remarkable(platelet, be high in infection)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.86
Salient(platelet, be low in kidney disease) ⋁
Evidence: 0.82
¬ Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.67
¬ Remarkable(platelet, be low in kidney disease)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.78
Plausible(platelet, be low in kidney disease) ⋁
Evidence: 0.82
¬ Typical(platelet, be low in kidney disease)

Typicality and Rermarkability incompatibility between a parent and a child

0.14
Rule weight: 0.51
Evidence weight: 0.34
Similarity weight: 0.80
Evidence: 0.67
¬ Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.99
¬ Typical(blood transfusion, be given to cancer patients)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.43
Similarity weight: 0.85
Evidence: 0.67
¬ Remarkable(platelet, be low in kidney disease) ⋁
Evidence: 0.86
¬ Typical(neutrophil, be low in leukemia)

Typicality inheritance from parent to child

0.32
Rule weight: 0.48
Evidence weight: 0.82
Similarity weight: 0.80
Evidence: 0.82
Typical(platelet, be low in kidney disease) ⋁
Evidence: 0.99
¬ Typical(blood transfusion, be given to cancer patients)